Journal ArticleDOI
Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN
TLDR
Results provide further support for the use of inhibitors of platelet reactions in conjunction with administration of fibrinolytic agents and suggest platelets freed from a thrombus may have increased responsiveness to low concentrations of aggregating agents other than thrombin.Abstract:
Effects of plasmin on platelets, that influence subsequent responses to aggregating agents, are relevant to attempts to prevent rethrombosis following administration of fibrinolytic agents. We describe plasmin-induced inhibition of platelet responses to thrombin, but potentiation of responses to other aggregating agents. Washed human platelets were labeled with 14C-serotonin, treated for 30 min at 37 degrees C with 0, 0.1 or 0.2 CU/ml of plasmin, followed by aprotinin, washed and resuspended in a Tyrode-albumin solution with apyrase. Incubation with 0.2 CU/ml of plasmin almost completely inhibited thrombin-induced (0.1 U/ml) aggregation, release of 14C-serotonin, and increase in cytosolic [Ca2+]. In contrast, with plasmin-pretreated platelets, aggregation and release of 14C-serotonin were strongly potentiated in response to low concentrations of the thrombin receptor-activating peptide SFLLRN, ADP, platelet-activating factor, collagen, arachidonic acid, the thromboxane mimetic U46619, and the calcium ionophores A23187 and ionomycin. Aspirin or RGDS partially inhibited potentiation. Plasmin-pretreated platelets resuspended in plasma anticoagulated with FPRCH2Cl (PPACK) also showed enhanced responses to aggregating agents other than thrombin. The contrasting effects on responses to thrombin and SFLLRN are noteworthy. Plasmin cleaves GPIIb/IIIa so that it becomes a competent fibrinogen receptor, and binding of 125I-fibrinogen during ADP-induced aggregation was greatly potentiated within 10 s. Potentiation of aggregation by other agonists may be due to increased binding of released fibrinogen. Thus, platelets freed from a thrombus may have increased responsiveness to low concentrations of aggregating agents other than thrombin. These results provide further support for the use of inhibitors of platelet reactions in conjunction with administration of fibrinolytic agents.read more
Citations
More filters
Journal ArticleDOI
Platelet microparticles: a wide-angle perspective.
Lawrence L. Horstman,Yeon S. Ahn +1 more
TL;DR: This work presents a meta-analyses of PMP quantitation through flow cytometry and ‘‘functional’’ assays, which demonstrates the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals.
Journal ArticleDOI
Plasmin Induces Cyr61 Gene Expression in Fibroblasts Via Protease-Activated Receptor-1 and p44/42 Mitogen-Activated Protein Kinase--Dependent Signaling Pathway
Usha R. Pendurthi,Mylinh Ngyuen,Patricia Andrade-Gordon,Lars Christian Petersen,L. Vijaya Mohan Rao +4 more
TL;DR: The aim of the present study was to elucidate potential mechanisms by which plasmin affects various cellular processes, and induced an angiogenic and wound-healing promoter, Cyr61, in fibroblasts through activation of PAR-1.
Journal ArticleDOI
Identification of thrombin receptors in rat brain capillary endothelial cells.
TL;DR: Using the reverse transcriptase-polymerase chain reaction method, the present study shows that primary cultures of rat brain capillary endothelial (RBCE) cells and astrocytes derived from rat brain express at least two receptors for thrombin, PAR-1 and PAR-3, and probably both receptors are involved inThrombin-induced [Ca2+]i signals.
Journal ArticleDOI
Interaction of viper venom serine peptidases with thrombin receptors on human platelets.
Beatriz F. Santos,Beatriz F. Santos,Solange M.T. Serrano,Athan Kuliopulos,Stefan Niewiarowski +4 more
TL;DR: Both PAR1 and PAR4 mediate the effect of viper venom serine peptidases on platelets, and both viper enzymes caused calcium mobilization in fibroblasts transfected with PAR4 and desensitized these cells to the thrombin action.
Journal ArticleDOI
Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
Marcus E. McKenzie,Alex I. Malinin,Christopher R. Bell,Alex Dzhanashvili,Eric D. Horowitz,Benjamin Oshrine,Dan Atar,Victor L. Serebruany +7 more
TL;DR: It appears that aspirin exhibits direct effects on selective major platelet receptors, in addition to the known effect of irreversibly inhibiting platelet cyclooxygenase‐1, thereby blocking thromboxane A2 synthesis.